Related Experiment Video
Updated: Jun 6, 2026

06:40
Biofunctionalization of Magnetic Nanomaterials
Published on: July 16, 2020
Inorganic nanoparticles in cancer therapy
Sanjib Bhattacharyya1, Rachel A Kudgus, Resham Bhattacharya
1Department of Biochemistry and Molecular Biology College of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
Pharmaceutical Research
|November 25, 2010
Summary
This study explores inorganic nanoparticles for cancer therapy. Gold, silver, and platinum nanoparticles show promise as drug delivery systems and therapeutic agents, though challenges remain.
Area of Science:
- Biomedical Nanotechnology
- Materials Science
Background:
- Nanotechnology offers unique biomedical applications due to nanoparticle size- and shape-dependent properties.
- Inorganic nanoparticles, particularly gold, silver, and platinum, are gaining attention for medical uses.
Purpose of the Study:
- To review recent advancements in using gold, silver, and platinum nanoparticles for cancer therapy.
- To discuss their dual role as drug delivery vehicles and therapeutic agents.
- To identify key challenges for future research in nanoparticle-based cancer treatment.
Main Methods:
- Literature review of recent developments in nanotechnology for cancer therapy.
- Focus on gold, silver, and platinum nanoparticles.
- Analysis of their application as delivery systems and therapeutic agents.
Main Results:
- Gold, silver, and platinum nanoparticles exhibit significant potential in cancer treatment.
- These nanoparticles can function both as carriers for therapeutic drugs and as direct therapeutic agents.
- Current research highlights their versatility in overcoming cancer treatment limitations.
Conclusions:
- Inorganic nanoparticles represent a promising frontier in oncology.
- Further research is crucial to address challenges and optimize nanoparticle-based cancer therapies.
- Continued investigation into delivery mechanisms and therapeutic efficacy is warranted.
More Related Videos
Related Concept Videos
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

